Clinical trial registry record

Metabolic Dysregulation as Biomarker of Frailty: Role of the Mitochondrial Dysfunction

A registered study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Unknown.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated May 29, 2024.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT06433427
Last registry update
May 29, 2024
Status
Unknown
Phase
Phase not reported
Sponsor
University Hospital of Ferrara
Enrollment
75
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
OBSERVATIONAL
Evidence population
Human clinical study registration
Participants
75
Population
ALL · 65 Years
Duration
2024-05-29 to 2026-02-22
Intervention
Comparator
Not reported
Outcomes measured
Difference in the mtDNA copy number between frail individuals with vs without multimorbidity — Baseline; Difference in the mtDNA copy number between non-frail vs frail individuals without multimorbidity — Baseline; Variation in the mean intensity of mitochondrial fluorescence between non-frail vs frail individuals without multimorbi…; Variation in the mean intensity of mitochondrial fluorescence between frail individuals with vs without multimorbidity…; Difference of intracellular Reactive Oxygen Species (ROS) between non-frail vs frail individuals without multimorbidity…; Difference of intracellular Reactive Oxygen Species (ROS) between frail individuals with vs without multimorbidity — Ba…; Qualitative difference in metabolomics profiles of PBMCs and PBMC subpopulations between non-frail vs frail individuals…; Qualitative difference in metabolomics profiles of PBMCs and PBMC subpopulations between frail individuals with vs with…
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Mitochondrial function · 100%Title contains controlled term: mitochondrial dysfunction. Abstract contains controlled term: mitochondrial dysfunction. Source terminology contains: mitochondrial dysfunction. Title supplies longevity context: frailty, frail. Study type is explicitly identified as OBSERVATIONAL.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

mitochondrial function
Open primary sourceExport JSON